Trexquant Investment LP - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 118 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.92 and the average weighting 1.0%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$250,170
-42.0%
50,336
-42.3%
0.01%
-41.7%
Q1 2023$431,064
-38.7%
87,260
-22.0%
0.01%
-40.0%
Q4 2022$703,757
+316.4%
111,885
+653.3%
0.02%
+150.0%
Q2 2022$169,000
-73.3%
14,853
-38.9%
0.01%
-84.9%
Q2 2021$634,000
+49.9%
24,321
+117.0%
0.05%
+96.3%
Q3 2020$423,000
-35.3%
11,207
-26.7%
0.03%
-40.0%
Q2 2020$654,000
+22.5%
15,280
-44.4%
0.04%
+15.4%
Q1 2020$534,000
+46.3%
27,481
+95.5%
0.04%
+77.3%
Q4 2019$365,00014,0600.02%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$45,386,0009.32%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$472,400,0005.23%
Wildcat Capital Management, LLC 1,515,524$38,252,0004.81%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 900,143$22,720,0003.28%
Coastal Bridge Advisors, LLC 385,824$9,738,0001.93%
Casdin Capital, LLC 945,000$23,852,0000.71%
DSAM Partners (London) Ltd 208,798$5,270,0000.62%
BAINCO INTERNATIONAL INVESTORS 152,839$3,858,0000.44%
Pier Capital, LLC 152,071$3,838,0000.41%
Woodline Partners LP 567,539$14,325,0000.38%
View complete list of ALLOGENE THERAPEUTICS INC shareholders